Skip to main content

Table 5 Separating the effects of fat mass and fat free mass on prostate cancer

From: Obesity, body composition, and prostate cancer

   Gleason 6 PC Gleason 7 PC Gleason 8-10 PC
   OR 95% CI OR 95% CI OR 95% CI
FM* kg 0.987 0.974, 1.001 0.999 0.983, 1.015 1.005 0.983, 1.027
FFM kg 1.015 0.997, 1.033 1.030 1.008, 1.052 1.044 1.014, 1.074
   OR 95% CI OR 95% CI OR 95% CI
FM** Q1 1.0 reference 1.0 reference 1.0 reference
  Q2 0.99 0.70, 1.40 1.13 0.73, 1.74 0.79 0.40, 1.56
  Q3 0.86 0.60, 1.24 1.19 0.75, 1.89 1.48 0.76, 2.88
  Q4 0.75 0.50, 1.11 1.24 0.76, 2.01 0.97 0.47, 1.98
FFM Q1 1.0 reference 1.0 reference 1.0 reference
  Q2 1.03 0.72, 1.46 0.96 0.63, 1.46 1.02 0.52, 1.97
  Q3 1.54 1.07, 2.21 1.07 0.68, 1.69 2.18 1.15, 4.27
  Q4 1.32 0.88, 2.00 1.53 0.94, 2.50 2.62 1.26, 5.45
  1. Table 5 includes analyses that describe the association between FFM or FM on PC after controlling for either FM or FFM. Analyses evaluate FM and FFM as either continuous variables or at quartiles
  2. * PC = FM (continuous), FFM (continuous), age, prostate volume, PSA, race, family history, and current treatment for diabetes, CVD, BPH, and hyperlipidemia
  3. ** PC = FM (Quartiles), FFM (Quartiles), age, prostate volume, PSA, race, family history, and current treatment for diabetes, CVD, BPH, and hyperlipidemia